No abstract available
MeSH terms
-
Antineoplastic Agents, Alkylating / administration & dosage*
-
Antineoplastic Agents, Alkylating / adverse effects
-
Brain Neoplasms / drug therapy*
-
Brain Neoplasms / mortality
-
Brain Neoplasms / pathology
-
Brain Neoplasms / radiotherapy
-
Brain Neoplasms / surgery
-
Chemotherapy, Adjuvant
-
Dacarbazine / administration & dosage
-
Dacarbazine / adverse effects
-
Dacarbazine / analogs & derivatives*
-
Disease Progression
-
Disease-Free Survival
-
Glioma / drug therapy*
-
Glioma / mortality
-
Glioma / pathology
-
Glioma / radiotherapy
-
Glioma / surgery
-
Humans
-
Radiotherapy, Adjuvant
-
Recurrence
-
Temozolomide
-
Time Factors
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Alkylating
-
Dacarbazine
-
Temozolomide